Chemed Corporation (CHE) stock analysis
In our weekly check, Chemed Corporation is graded B (A to F). Of 25 checks on debt, profit, cash flow and trend: 20 pass, warnings: 4, red flags: 1.
About Chemed Corporation
Chemed Corporation is a Healthcare company (Medical Care Facilities) based in the United States, listed on NYSE as CHE.
What our checks show for CHE
Red flags
- The gross margin fell by 4.3 points, to 31.7%: costs are rising faster than prices.
Warning signs
- The net margin fell by 1.9 points over 5 years, to 10.6%: the company keeps less of each sale as profit.
- The stock has fallen as much as 55% from a peak. Would you have held through that?
- Recovering from its deepest fall took about 2.5 years.
- Thinly traded (about 151 thousand shares a day): buying and selling can move the price.
Strengths
- Net debt is only 0.8x a year of EBITDA: the balance sheet has room.
- Operating profit covers interest 75.4 times over.
- Operating cash flow is 1.29x net profit: the profit arrives as real cash.
- Analysts expect earnings per share to grow about 18.3% a year over the next years.
- Analysts expect the net margin to improve by 3.7 points from today's 10.6%.
- Free cash flow is 11.1% of revenue: cash for dividends, buybacks or growth.
Similar companies
PACS · LFST · UHS · OPCH · DVA · ENSG
Questions
What grade does Chemed Corporation (CHE) have?
In our weekly check, Chemed Corporation is graded B (A to F). Of 25 checks on debt, profit, cash flow and trend: 20 pass, warnings: 4, red flags: 1. The grade is a risk check, not a buy or sell recommendation.
What are the main risks of CHE stock?
This week's biggest flags for Chemed Corporation: Gross margin falling, Margins falling, Deep past fall. In total 5 of 25 checks show a warning or a red flag.
What does Chemed Corporation do?
Chemed Corporation is a Healthcare company (Medical Care Facilities) based in the United States, listed on NYSE as CHE.
The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.
Updated 2026-11-14
Open the full analysis